EcoDrugPlus

Ensembl ID : HMEL014661
Gene Symbol: -
External references: -
76 Possible Orthologues:

Ensembl ID : HMEL014719
Gene Symbol: -
External references: -
73 Possible Orthologues:

Ensembl ID : HMEL014742
Gene Symbol: -
External references: -
606 Possible Orthologues:

Ensembl ID : HMEL014784
Gene Symbol: -
External references: -
2128 Possible Orthologues:

Ensembl ID : HMEL014792
Gene Symbol: -
External references: -
262 Possible Orthologues:

Ensembl ID : HMEL014794
Gene Symbol: -
External references: -
270 Possible Orthologues:

Ensembl ID : HMEL014795
Gene Symbol: -
External references: -
307 Possible Orthologues:

Ensembl ID : HMEL014803
Gene Symbol: -
External references: -
225 Possible Orthologues:

Ensembl ID : HMEL014812
Gene Symbol: -
External references: -
535 Possible Orthologues:

Ensembl ID : HMEL014821
Gene Symbol: -
External references: -
551 Possible Orthologues:

Ensembl ID : HMEL014861
Gene Symbol: -
External references: -
97 Possible Orthologues:

Ensembl ID : HMEL014866
Gene Symbol: -
External references: -
137 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).